Article
Multidrug resistance proteins in rhabdomyosarcomas
1 Apr 2003
Abstract excerpt
BACKGROUND: Pediatric rhabdomyosarcomas (RMS) have a more advantageous prognosis after multimodality treatment compared with adult RMS, which might be related to a decreased sensitivity to chemotherapy in adults. Resistance to chemotherapy might be conveyed by the multidrug resistance (MDR)-associated proteins P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1), and lung resistance-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
